H Shigematsu

920 total citations
39 papers, 757 citations indexed

About

H Shigematsu is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, H Shigematsu has authored 39 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in H Shigematsu's work include Renal Diseases and Glomerulopathies (13 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Vasculitis and related conditions (4 papers). H Shigematsu is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Vasculitis and related conditions (4 papers). H Shigematsu collaborates with scholars based in Japan, South Korea and United States. H Shigematsu's co-authors include Yōichirō Kondō, Yuya Kobayashi, Yutaka Kobayashi, Akio Kôyama, Noboru Harada, Masaki Osawa, Keigi Fujiwara, Michitaka Masuda, Hiroshi Yasuhara and Yoshinori Kobayashi and has published in prestigious journals such as FEBS Letters, Neuroscience and QJM.

In The Last Decade

H Shigematsu

39 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Shigematsu Japan 16 271 170 166 113 101 39 757
J. van den Born Netherlands 14 163 0.6× 183 1.1× 195 1.2× 87 0.8× 117 1.2× 25 673
Meiying Qi United States 16 316 1.2× 486 2.9× 259 1.6× 53 0.5× 98 1.0× 18 1.1k
Gerald S. Spear United States 15 136 0.5× 244 1.4× 50 0.3× 92 0.8× 107 1.1× 38 693
Timothy Semple Australia 21 244 0.9× 296 1.7× 542 3.3× 75 0.7× 168 1.7× 28 1.2k
Joost F.M. Lensen Netherlands 16 255 0.9× 323 1.9× 86 0.5× 127 1.1× 38 0.4× 22 797
Jacob van den Born Netherlands 17 447 1.6× 485 2.9× 126 0.8× 150 1.3× 104 1.0× 23 1.3k
Toshiyuki Imasawa Japan 18 315 1.2× 511 3.0× 119 0.7× 46 0.4× 91 0.9× 61 1.1k
E Mandache Romania 16 168 0.6× 321 1.9× 106 0.6× 18 0.2× 84 0.8× 54 892
Amberly Brown United States 10 460 1.7× 158 0.9× 182 1.1× 21 0.2× 94 0.9× 16 906
Fumiaki Nogaki Japan 16 174 0.6× 358 2.1× 219 1.3× 20 0.2× 77 0.8× 39 951

Countries citing papers authored by H Shigematsu

Since Specialization
Citations

This map shows the geographic impact of H Shigematsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Shigematsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Shigematsu more than expected).

Fields of papers citing papers by H Shigematsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Shigematsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Shigematsu. The network helps show where H Shigematsu may publish in the future.

Co-authorship network of co-authors of H Shigematsu

This figure shows the co-authorship network connecting the top 25 collaborators of H Shigematsu. A scholar is included among the top collaborators of H Shigematsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Shigematsu. H Shigematsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamijo, Yuji, Kenji Hashimoto, Ken Takahashi, et al.. (2011). Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis. Clinical Nephrology. 76(8). 136–143. 10 indexed citations
2.
Muto, Akihito, et al.. (2010). Prostaglandin receptors EP2 and IP are detectable in atherosclerotic arteries and plaques.. PubMed. 29(2 Suppl). 43–8. 2 indexed citations
3.
Saito, Tami, Yoshio Hosoi, Takashi Komiyama, et al.. (2005). Impaired ambulatory venous function in lymphedema assessed by near-infrared spectroscopy.. PubMed. 24(4). 336–9. 5 indexed citations
4.
Kaneko, Yoko, Yuji Kamijo, Naoya Kobayashi, et al.. (2003). Younger onset myeloperoxidase-specific antineutrophil cytoplasmic antibody- (MPO-ANCA) related glomerulonephritis accompanied with nephrotic syndrome. Clinical Nephrology. 60(10). 275–278. 2 indexed citations
5.
Taniguchi, Shun’ichiro, Michiko Takeoka, Takashi Ehara, et al.. (2001). Structural fragility of blood vessels and peritoneum in calponin h1-deficient mice, resulting in an increase in hematogenous metastasis and peritoneal dissemination of malignant tumor cells.. PubMed. 61(20). 7627–34. 42 indexed citations
6.
Hora, Kazuhiko, Yoko Kaneko, Tohru Yamazaki, et al.. (2000). Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report. Transplantation Proceedings. 32(1). 223–226. 11 indexed citations
7.
Yasuhara, Hiroshi, et al.. (2000). Direct and indirect effects of pulsatile shear stress on the smooth muscle cell.. PubMed. 19(1). 39–46. 18 indexed citations
8.
Kitahara, Masashi, Kentaro Koike, Nobukuni Sawai, et al.. (1999). Lupus nephritis in juvenile myelomonocytic leukemia.. PubMed. 51(5). 314–8. 8 indexed citations
9.
Kitahara, Masashi, et al.. (1999). Altered metabolism of extracellular matrix as a cause of progression of glomerulonephritis. Nephrology. 5(s1). 1 indexed citations
10.
Masuda, Michitaka, Masaki Osawa, H Shigematsu, Noboru Harada, & Keigi Fujiwara. (1997). Platelet endothelial cell adhesion molecule‐1 is a major SH‐PTP2 binding protein in vascular endothelial cells. FEBS Letters. 408(3). 331–336. 88 indexed citations
11.
Tateno, Shigeru, Yosio Hiki, K Hamaguchi, et al.. (1991). Study of Lupus Nephritis in Males. QJM. 81(3). 1031–1039. 15 indexed citations
12.
Shigematsu, H & Shino Murakami. (1990). Intrarenal reflux and nephropathy.. PubMed. 32(3). 331–7. 2 indexed citations
13.
Shigematsu, H & Akio Kôyama. (1988). Therapeutic effect of cyclosporin A and steroid on serum sickness type nephritis in the rat. 2. Suppressive effect on full-blown proliferative glomerulonephritis.. PubMed. 30(9). 1115–22. 5 indexed citations
15.
Chen, Xiangmei, Toshiyuki Tanaka, Yoshinori Kobayashi, H Shigematsu, & Ko Okumura. (1987). Experimental glomerulonephritis induced by immune complexes of monoclonal antibodies produced by immunoglobulin class-switch variants.. PubMed. 57(6). 665–72. 2 indexed citations
16.
Shigematsu, H, Yoshio Kobayashi, Shigeru Tateno, & Misao Tsukada. (1980). Ultrastructure of acute glomerular injury in IgA nephritis.. PubMed. 104(6). 303–7. 14 indexed citations
17.
Kôyama, Akio, et al.. (1978). Studies on passive serum sickness. II. Factors determining the localization of antigen-antibody complexes in the murine renal glomerulus.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(3). 253–62. 53 indexed citations
18.
Shigematsu, H & Yutaka Kobayashi. (1976). Accelerated serum sickness in the rabbit. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 369(4). 269–282. 27 indexed citations
19.
Shigematsu, H, et al.. (1972). Participation of monocytes in transient glomerular hypercellularity in poststreptococcal glomerulonephritis. Virchows Archiv B Cell Pathology. 12(1). 367–370. 27 indexed citations
20.
Shigematsu, H. (1970). Glomerular events during the initial phase of rat Masugi nephritis.. PubMed. 5(3). 187–200. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026